Cn1c2cc(Br)sc2c2cnn(Cc3c(F)cccc3Cl)c(=O)c21
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?